Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HAND IN Insulin-001: Intranasal Treatment of HIV-associated Neurocognitive Disorders

NCT03277222 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT03277222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03277222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HAND IN Insulin-001: Intranasal Treatment of HIV-associated Neurocognitive Disorders
Lead sponsor
University of Calgary
Phase
Phase 2
Overall status
Terminated
Start date
November 1, 2018
Completion date
April 21, 2019
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv associated neurocognitive disorder (hand)